Showing results (141-150 of 636) with videos related to

Sort By:
Pageof 64
British Journal of Haematology|November 21, 2007
MicroRNAs in the pathogeny of chronic lymphocytic leukaemiaMilena S Nicoloso, Thomas J Kipps, Carlo M Croce, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2008
MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancerMarilena V Iorio, Patrizia Casalini, Elda Tagliabue, et al.
Scientific Reports|May 10, 2017
Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cellsXinhui Zhou, Weijin Liu, Xing Hu, et al.
Oncotarget|May 17, 2017
P53 suppresses ribonucleotide reductase via inhibiting mTORC1Zhengfu He, Xing Hu, Weijin Liu, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemiasGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.
Cancer Science|June 3, 2009
Fragile gene product, Fhit, in oxidative and replicative stress responsesHiroshi Okumura, Hideshi Ishii, Flavia Pichiorri, et al.
Genes & Cancer|July 23, 2011
MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic CancerAruna Basu, Hansjuerg Alder, Amer Khiyami, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2019
isoTar: Consensus Target Prediction with Enrichment Analysis for MicroRNAs Harboring Editing Sites and Other VariationsRosario Distefano, Giovanni Nigita, Dario Veneziano, et al.
Cancer Research|February 7, 2007
Molecular and cytogenetical alterations induced by environmental cigarette smoke in mice heterozygous for FhitSilvio De Flora, Francesco D'Agostini, Alberto Izzotti, et al.
Cancers|April 30, 2021
Detecting and Characterizing A-To-I microRNA Editing in CancerGioacchino P Marceca, Luisa Tomasello, Rosario Distefano, et al.
Pageof 64